Melinda Preston
Nurse Practitioner · Phoenix, AZNPI 1285617449
Payments from drug & device makers
Across 381 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$863
- AbbVie$641
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$489
- Johnson & Johnson$412
- Lilly USA, LLC$365
- Argenx US, Inc.$343
- plus $4K from 49 others
What the payments were for
- Speaking & faculty fees$130%
- Food & beverage$7,00499%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$125
How this compares
$7,088 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 22 | $47,675 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 132 | $8,874 |
| Nefazodone Hcl | 27 | $4,428 |
| Lurasidone Hcl | 23 | $3,346 |
| Clonazepam | 133 | $2,817 |
| Lamotrigine | 119 | $2,753 |
| Ziprasidone Hcl | 67 | $2,537 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $2,535 |
| Bupropion XlBupropion Hcl | 42 | $1,473 |
| Escitalopram Oxalate | 89 | $1,183 |
| Aripiprazole | 46 | $876 |
| Mirtazapine | 30 | $754 |
| Duloxetine Hcl | 31 | $750 |
| Trazodone Hcl | 84 | $712 |
| Donepezil Hcl | 16 | $704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $489 | $47,67522 claims |
| Almatica Pharma LLCSertraline Hcl | $69 | $18027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Phoenix
- Helena In't VeldPhoenix$64K
- Dustin NickersonPhoenix$39K
- Ryan MobleyPhoenix$22K
- Anita PalandriPhoenix$20K
- Kristina WernerPhoenix$19K
- Miranda IsomPhoenix$17K
- Catherine LynnPhoenix$16K
- Edith GazoPhoenix$15K
- Dora QuanPhoenix$14K
- Rachael BennettPhoenix$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.